PNET

8 registered clinical trials studyying PNET — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial NCT07167329	José Claudio Casali da Rocha	Phase 2
Completed	Rare CNS Tumors Outcomes &Risk NCT03251989	National Cancer Institute (NCI)	—
Completed	HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain NCT02457845	Gregory K. Friedman, MD	Phase 1
Terminated	Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lym NCT02110563	Dicerna Pharmaceuticals, Inc., a Novo Nordisk company	Phase 1
Terminated	A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes NCT01251913	National Cancer Institute (NCI)	—
Withdrawn	A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas NCT01117155	National Cancer Institute (NCI)	—
Completed	A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With NCT00994071	National Cancer Institute (NCI)	Phase 1
Completed	Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors NCT01445288	National Cancer Institute (NCI)	—